Clinical Trial Update: Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nicotinamide riboside for prevention of small fiber axon degeneration and promotion of nerve regeneration in small fiber neuro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Fiber Neuropathy

Drugs mentioned

• Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: Johns Hopkins University | Conditions: Small Fiber Neuropathy | Phase 2 | Status: COMPLETED | Results posted: 2024-06-06